Archive for September 2021
Stryker buys Gauss Surgical for its AI tech that tracks blood loss during childbirth
Original Source Stryker has snatched up Gauss Surgical after being drawn to its artificial intelligence-powered platform for monitoring a patient’s blood loss during surgery as well as following cesarean sections and childbirth. The company’s Triton system uses a computer vision app and an iPhone to visually measure a person’s loss of blood by capturing images of sponges,…
Read MoreGilbert Family Foundation Funds Clinical Study to Understand Vision Loss from NF1 Optic Pathway Glioma
Original Source September 14th, 2021 [DETROIT, MI] – The Gilbert Family Foundation, a private nonprofit established by Jennifer and Dan Gilbert to accelerate a cure for neurofibromatosis type 1 (NF1), today announced funding of a new $5.4 million clinical study. The study, to be led by investigators at Children’s Hospital of Philadelphia and the Stanford University School…
Read MoreNeogen acquires pet medications maker CAPInnoVet
Original Source LANSING — Food and animal safety products maker Neogen Corp. has bolstered its holding in the fast-growing veterinary market with the acquisition of an Atlanta-based companion animal health company. On Monday, Lansing-based Neogen (Nasdaq: NEOG) said it acquired CAPInnoVet Inc., a provider of pet medications that offer protection from fleas, ticks and mosquitoes at what…
Read MorePhenomics Health Validates Patented Technology Following Seed Financing Personalized Medicine for Medication Selection and Monitoring
Plymouth, MI – September 22, 2021 – Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced completion of clinical product development and validation for its PrecīsMed™ pharmacometabolomics (PMx) technology in its new CLIA laboratory located at the Michigan Life Science and Innovation Center. The company’s laboratory operations, validation, as well as ongoing research…
Read MoreCayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
ANN ARBOR, MI, September 16, 2021 — The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone. The…
Read MoreFDA Approves First COVID-19 Vaccine
Original Source Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency…
Read More